Related Experiment Videos
Cell salvage auto transfusion in total knee replacement surgery
A Shenolikar1, K Wareham, D Newington
1Department of Anaesthesia, Morriston Hospital, Swansea, UK.
Transfusion Medicine (Oxford, England)
|March 25, 1998
Summary
Cell salvage autologous blood transfusion significantly reduced the need for allogeneic blood transfusions in total knee replacement patients. This method is safe and effective, lowering infection risks and conserving blood reserves.
Area of Science:
- Orthopedic Surgery
- Transfusion Medicine
Background:
- Allogeneic blood transfusions carry risks, including infection transmission.
- Minimizing allogeneic blood use is crucial for patient safety and resource management.
Purpose of the Study:
- To evaluate the efficacy of cell salvage autologous blood transfusion in total knee replacement (TKR) surgery.
- To compare the requirement for allogeneic blood transfusions between autologous and allogeneic transfusion groups.
Main Methods:
- Prospective, randomized study involving 100 TKR patients.
- Patients were allocated to either cell salvage autologous transfusion or standard allogeneic transfusion.
- Autologous group received allogeneic rescue if hemoglobin dropped below 9 g/dL.
Main Results:
- 84% of patients in the autologous group (42/50) did not require supplementary allogeneic blood.
- 80% of patients in the allogeneic group (40/50) required a transfusion.
- No adverse effects were observed in the autologous transfusion group.
Conclusions:
- Cell salvage autologous blood transfusion is a safe and effective strategy for reducing allogeneic blood use in TKR.
- This approach decreases the risk of transfusion-transmitted infections and conserves allogeneic blood resources.